DeNovix Collaborates with Bay Area “Hackerspace” BioCurious
News Nov 05, 2014
DeNovix Inc. has donated instrumentation to BioCurious, a unique collaboration lab based in the San Francisco Bay area. DeNovix has supplied the company’s flagship product, the DS-11 Spectrophotometer, to the facility for use by life science research teams at BioCurious. DeNovix strongly supports the BioCurious belief that “innovations in biology should be accessible, affordable and open to everyone”. The facility is a community biology lab for use by entrepreneurs, amateurs and professional scientists interested in conducting biotech research.
The DeNovix DS-11 is used in genomic and proteomic research laboratories for quantification of nucleic acid and protein samples. The instrument is a necessity in nearly any bioresearch workflow. The DeNovix instrument is intuitive and geared toward today’s tech-savvy researcher. The system utilizes a custom Android™ operating system eliminating the need for a PC and saving critical bench space. The system features a glove compatible, 7” HD touch screen and all measurements are made using intuitive EasyApps® designed by DeNovix for the most common life science applications.
“The placement at BioCurious is a real win-win arrangement,” stated Fred Kielhorn, Managing Director of DeNovix Inc. “Who knows what ideas can develop from a facility when the barriers for interactivity amongst bright, creative and driven science-minded researchers are eliminated. We hope our instrument can be a small part of a really big idea that gets its start at BioCurious.”
“At BioCurious, we’re proving that breakthroughs in biotech come from amateurs and professionals alike. It’s essential that we use new tools to automate and accelerate otherwise complicated techniques” said Tito Jankowski, co-founder of BioCurious, “Being able to quantify a DNA sample in seconds using the DeNovix DS-11 gives us major insights into experimental progress. It’s an essential part of our lab’s toolkit.”
Neuroblastoma Biomarker Research Advances TreatmentNews
Neuroblastoma, a childhood cancer, is treatable in less than half of aggressive cases, but new RNA biomarkers may help identify high-risk patients faster and lead to better prognosis.READ MORE
The Exercise Regime of the Future Needs to Check Your GenesNews
Forget protein bars - genes may be central to the exercise regimes of the future, as scientists track down gene changes which occur in response to exercise.READ MORE